tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Sean Lee, 76 are a BUY (88.37%), 10 are a HOLD (11.63%).
Analyst Sean Lee, carries an average stock price target met ratio of 33.11% that have a potential upside of 47.02% achieved within 142 days. Previously, Sean Lee worked at HCWAINWRIGHT.
Sean Lee’s has documented 161 price targets and ratings displayed on 15 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on CRVS, Corvus Pharmaceuticals at 20-Jan-2026.
Analyst best performing recommendations are on MNPR (MONOPAR THERAPEUTICS).
The best stock recommendation documented was for MNPR (MONOPAR THERAPEUTICS) at 1/22/2025. The price target of $40 was fulfilled within 2 days with a profit of $6.33 (18.8%) receiving and performance score of 94.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 22-May-2023
$4
$2.98 (292.16%)
$4
5 months 10 days ago
(03-Sep-2025)
1/7 (14.29%)
$1.67 (71.67%)
54
Buy Since 17-May-2021
$4
3 years 2 months 28 days ago
(16-Nov-2022)
1/2 (50%)
$0.72 (21.95%)
73
Buy Since 24-Mar-2020
$12
$10.98 (1076.47%)
3 years 5 months 29 days ago
(15-Aug-2022)
1/2 (50%)
$7.98 (198.51%)
308
Buy
$50
3 years 8 months 18 days ago
(26-May-2022)
0/1 (0%)
$32.3 (182.49%)
Which stock is Sean Lee is most bullish on?
Which stock is Sean Lee is most reserved on?
What Year was the first public recommendation made by Sean Lee?
